You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARID1A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • mCRC
  • Tislelizumab & Fruquintinib
  • Guangzhou, Guangdong, China
  • +1 more
Jan 25, 2023

Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))

Not yet recruiting
  • Solid Tumors
  • +4 more
  • JAB-2485 (Aurora A inhibitor)
  • (no location specified)
Aug 4, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in Houston (Nivolumab)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Solid Neoplasm
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 1, 2021

Gynecologic Tumors, Epithelial Ovarian Cancer Trial in Canada, United States (PLX2853, Carboplatin)

Terminated
  • Gynecologic Neoplasms
  • Epithelial Ovarian Cancer
  • Chicago, Illinois
  • +8 more
Jul 19, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Metastatic Adenocarcinoma Trial (Belinostat, nivolumab, ipilimumab)

Withdrawn
  • Metastatic Adenocarcinoma
  • (no location specified)
Oct 26, 2020

Gynaecological Cancers Trial in London (AZD6738, Olaparib)

Recruiting
  • Gynaecological Cancers
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Sep 2, 2020

NSCLC Stage IV, ARID1A, PD-1 Trial in Qingdao (PD-1 plus Dasatinib)

Unknown status
  • NSCLC Stage IV
  • +2 more
  • PD-1 plus Dasatinib
  • Qingdao, China
    The Affiliated Hospital of Qingdao University
Feb 24, 2020

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

    Completed
    • Mesothelioma
    • +3 more
    • Gainesville, Florida
    • +2 more
    Jan 4, 2023

    Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

    Not yet recruiting
    • Melanoma
    • Fluzoparib Camrelizumab Temozolomide
    • (no location specified)
    Aug 9, 2023

    Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

    Completed
    • Small Cell Lung Cancer
    • +7 more
    • Scottsdale, Arizona
    • +4 more
    Jul 20, 2022

    Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma

    Active, not recruiting
    • Recurrent Endometrial Endometrioid Adenocarcinoma
    • +4 more
    • Anchorage, Alaska
    • +584 more
    Jan 28, 2023

    Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

    Recruiting
    • Gastric Cancer
    • GastroEsophageal Cancer
    • Aurora, Colorado
    • +2 more
    Jan 4, 2023

    Cancer Trial in United States (AZD2281, AZD5363, AZD1775)

    Active, not recruiting
    • Cancer
    • New Haven, Connecticut
    • +3 more
    Sep 14, 2021

    Type 1 Diabetes, Type 1 Diabetes With Hypoglycemia, Type 1 Diabetes With Hyperglycemia Trial in Berne (Lab Demo 1.0)

    Not yet recruiting
    • Type 1 Diabetes Mellitus
    • +2 more
    • Lab Demo 1.0
    • Berne, Switzerland
      Markus Laimer
    Oct 23, 2023

    ALDH1A1 Expression in Invasive Mammary Carcinoma

    Enrolling by invitation
    • Breast Cancer
      • Sohag, Egypt
        Faculty of Medicine
      Nov 12, 2023

      Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)

      Not yet recruiting
      • Myotonic Dystrophy 1
      • ARO-DM1 for Injection
      • Placebo
      • (no location specified)
      Nov 14, 2023

      MicroRNA-1 and MicroRNA-133a Levels After Acute Exercise in

      Recruiting
      • To Determine the Levels of miRNA1 and miRNA133a Before and After Exercise
      • miRNA levels analysis from saliva samples
      • Istanbul, Turkey
        Yeditepe University
      Oct 11, 2023

      UGT1A1 Genotyping in Taiwanese Cancer Patients

      Not yet recruiting
      • The Influence of the UGT1A1 Genotype
        • (no location specified)
        Mar 20, 2023

        Metastatic Melanoma Trial in San Francisco (Niraparib)

        Recruiting
        • Metastatic Melanoma
        • San Francisco, California
          California Pacific Medical Center Research Institute
        Oct 15, 2021

        DM1 Patients in China

        Enrolling by invitation
        • Myotonic Dystrophy 1
        • Brain MRI scan
        • Shanghai, China
          Huashan Hospital
        Oct 20, 2023